---
figid: PMC7359912__fphys-11-00742-g007
figlink: pmc/articles/PMC7359912/figure/F7/
number: F7
caption: Restoring the platelet miR-223 by calpeptin alleviates the neointimal hyperplasia
  in diabetes through miR-223/IGF-1R/AMPK signaling pathway. MiR-223 deficiency in
  diabetic platelet failed to suppress VSMC proliferation during vascular injury.
  The platelet-derived miR-223 suppressed VSMC proliferation via the regulation IGF-1R/AMPK
  signaling pathways. Interestingly, treating with a calpeptin restores the downregulated
  expression of miR-223 in diabetic platelets to suppress VSMC proliferation via targeting
  IGF-1R and plays a protective role in diabetic neointimal hyperplasia.
pmcid: PMC7359912
papertitle: Restoring the Platelet miR-223 by Calpain Inhibition Alleviates the Neointimal
  Hyperplasia in Diabetes.
reftext: Meiling Su, et al. Front Physiol. 2020;11:742.
pmc_ranked_result_index: '34422'
pathway_score: 0.9615185
filename: fphys-11-00742-g007.jpg
figtitle: Restoring the platelet miR-223 by calpeptin alleviates the neointimal hyperplasia
  in diabetes through miR-223/IGF-1R/AMPK signaling pathway
year: '2020'
organisms:
- Mus musculus
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7359912__fphys-11-00742-g007.html
  '@type': Dataset
  description: Restoring the platelet miR-223 by calpeptin alleviates the neointimal
    hyperplasia in diabetes through miR-223/IGF-1R/AMPK signaling pathway. MiR-223
    deficiency in diabetic platelet failed to suppress VSMC proliferation during vascular
    injury. The platelet-derived miR-223 suppressed VSMC proliferation via the regulation
    IGF-1R/AMPK signaling pathways. Interestingly, treating with a calpeptin restores
    the downregulated expression of miR-223 in diabetic platelets to suppress VSMC
    proliferation via targeting IGF-1R and plays a protective role in diabetic neointimal
    hyperplasia.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1R
  - AKT2
  - AKT3
  - AKT1
  - GSK3B
  - PRKAG2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG3
  - ACACB
  - ACACA
  - H
  - Diabetes H
  - hyperplasia
genes:
- word: IGF-IR
  symbol: IGFIR
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: ΑMPΚα
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: ΑMPΚα
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: ΑMPΚα
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: ΑMPΚα
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: ΑMPΚα
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: ΑMPΚα
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: ΑMPΚα
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACB
  entrez: '32'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACA
  entrez: '31'
- word: IGF-1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
chemicals:
- word: H
  source: MESH
  identifier: D006859
diseases:
- word: Diabetes H
  source: MESH
  identifier: D003920
- word: hyperplasia
  source: MESH
  identifier: D006965
figid_alias: PMC7359912__F7
redirect_from: /figures/PMC7359912__F7
figtype: Figure
---
